[Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]

Area of Science:

• Cardiovascular Medicine
• Neuroscience
• Biochemistry

Background:

• Stroke is a leading cause of adult disability, with carotid atherosclerosis being a major risk factor.
• Unstable atherosclerotic plaques in carotid arteries contribute significantly to ischemic strokes.
• Osteoprotegerin (OPG) plays a role in bone remodeling and osteoclast differentiation.

Purpose of the Study:

• To review the role of Osteoprotegerin (OPG) as a potential biomarker and prognostic indicator for stroke.
• To explore the association between OPG levels, OPG genotypes, and carotid atherosclerosis.
• To evaluate OPG's predictive value for plaque instability and stroke risk.

Main Methods:

• Literature review of studies investigating Osteoprotegerin (OPG) in relation to stroke and cardiovascular diseases.
• Analysis of data on plasma OPG levels in patients with carotid artery stenosis and atherosclerotic plaques.
• Examination of the prevalence of specific OPG genotypes in individuals with unstable atherosclerotic plaques.

Main Results:

• Elevated plasma OPG levels are associated with increased risk of ischemic stroke and heart diseases.
• OPG is linked to symptomatic carotid artery stenosis and the presence of vulnerable atherosclerotic plaques.
• Certain OPG genotypes are significantly more common in individuals with unstable plaques, acting as independent risk predictors.

Conclusions:

• Osteoprotegerin (OPG) shows potential as a valuable biomarker for identifying individuals at high risk of stroke.
• OPG levels and genetic variations may serve as prognostic indicators for carotid plaque instability and subsequent stroke events.
• Further research into OPG's role could lead to improved stroke prevention strategies.